OUP user menu

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

W Haverkamp , G Breithardt , A.J Camm , M.J Janse , M.R Rosen , C Antzelevitch , D Escande , M Franz , M Malik , A Moss , R Shah
DOI: http://dx.doi.org/10.1053/euhj.2000.2249 1216-1231 First published online: 1 August 2000

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview